Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000981737 | SCV001129731 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001565737 | SCV001789138 | uncertain significance | not provided | 2023-05-19 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Observed with COL12A1 p.(T786M) in several individuals, suggesting these two variants may occur on the same allele (in cis) |
Ambry Genetics | RCV002548457 | SCV003744393 | uncertain significance | Inborn genetic diseases | 2021-10-22 | criteria provided, single submitter | clinical testing | The c.1517C>G (p.A506G) alteration is located in exon 10 (coding exon 9) of the COL12A1 gene. This alteration results from a C to G substitution at nucleotide position 1517, causing the alanine (A) at amino acid position 506 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001565737 | SCV003831226 | uncertain significance | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing |